Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GH

Guardant Health Inc

Sep 06 • 04:00PM ET

23.73

Dollar change -0.60
Percentage change -2.47	%

Healthcare • Diagnostics & Research • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VB IWM VXF VBK ARKG IWO VTWO VHT SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.09	Insider Own	4.99%	Shs Outstand	121.63M	Perf Week	-8.48%
Market Cap	2.92B	Forward P/E	-	EPS next Y	-2.85	Insider Trans	0.03%	Shs Float	116.88M	Perf Month	-30.12%
Income	-490.76M	PEG	-	EPS next Q	-0.75	Inst Own	95.30%	Short Float	8.03%	Perf Quarter	-18.23%
Sales	643.81M	P/S	4.53	EPS this Y	23.73%	Inst Trans	1.88%	Short Ratio	4.59	Perf Half Y	28.55%
Book/sh	-0.01	P/B	-	EPS next Y	12.83%	ROA	-28.46%	Short Interest	9.39M	Perf Year	-32.80%
Cash/sh	8.42	P/C	2.82	EPS next 5Y	29.20%	ROE	-337.16%	52W Range	15.81 - 37.04	Perf YTD	-12.27%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.88%	ROI	-37.41%	52W High	-35.93%	Beta	1.11
Dividend TTM	-	Quick Ratio	6.07	Sales past 5Y	49.27%	Gross Margin	59.87%	52W Low	50.09%	ATR (14)	1.45
Dividend Ex-Date	-	Current Ratio	6.40	EPS Y/Y TTM	16.79%	Oper. Margin	-79.30%	RSI (14)	31.06	Volatility	3.99% 4.87%
Employees	1779	Debt/Eq	-	Sales Y/Y TTM	26.20%	Profit Margin	-76.23%	Recom	1.38	Target Price	41.50
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-25.31%	Payout	-	Rel Volume	1.29	Prev Close	24.33
Sales Surprise	9.01%	EPS Surprise	-11.48%	Sales Q/Q	29.23%	Earnings	Aug 07 AMC	Avg Volume	2.05M	Price	23.73
SMA20	-13.72%	SMA50	-20.11%	SMA200	-3.80%	Trades		Volume	2,645,831	Change	-2.47%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-26-23	Upgrade	Citigroup	Neutral → Buy	$28 → $40
May-05-23	Initiated	UBS	Buy	$40
Mar-09-23	Downgrade	Citigroup	Buy → Neutral	$60 → $33
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$36
Nov-01-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $50
Oct-19-22	Initiated	Craig Hallum	Buy	$88
Oct-06-22	Initiated	Stephens	Overweight	$99
Aug-25-22	Initiated	Credit Suisse	Outperform	$80
Jun-03-22	Initiated	Piper Sandler	Overweight	$65
Apr-28-22	Resumed	BTIG Research	Buy	$135 → $115
Feb-24-22	Reiterated	Wells Fargo	Overweight	$150 → $115

Show Previous Ratings

Aug-27-24 04:05PM	Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-26-24 12:56PM	Midday movers: PDD Holdings, NVIDIA fall; Xpeng gains (Investing.com) -7.86%
10:40AM	Why Guardant Health Stock Just Crashed 10% (Motley Fool)
Aug-23-24 10:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
06:00AM	Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) (News Direct)
05:00PM	Loading…
Aug-22-24 05:00PM	Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield Blood Test for Colorectal Cancer Screening (Business Wire)
Aug-12-24 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) +5.07%
Aug-09-24 04:48PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Aug-08-24 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire) -10.87%
09:35AM	Guardant Health (GH) Recently Broke Out Above the 20-Day Moving Average (Zacks)
Aug-07-24 07:30PM	Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +5.60%
06:50PM	Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:49PM	Guardant Health: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (Business Wire)
08:05AM	Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer (Business Wire)
09:15AM	Loading…
Aug-06-24 09:15AM	What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 Earnings (Zacks) +5.27%
Aug-01-24 04:02PM	Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat (Investor's Business Daily) -5.04%
08:30AM	Guardant Healths FDA-approved Shield Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer (Business Wire)
08:00AM	Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies (Business Wire)
Jul-31-24 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jul-30-24 06:32AM	Guardant Health secures FDA approval for Shield test (Medical Device Network)
05:17AM	Guardant Health (GH) Moves 6.9% Higher: Will This Strength Last? (Zacks)
Jul-29-24 04:06PM	FDA approves Guardant Health's blood test for colon cancer (Yahoo Finance Video) +6.91%
02:16PM	Guardant Health Gets FDA Nod on Colorectal Cancer Blood Test (Investopedia)
07:58AM	Guardant wins FDA approval for colon cancer blood test (MedTech Dive)
06:30AM	Guardant Healths Shield Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening (Business Wire)
Jul-24-24 04:05PM	Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jul-23-24 08:05AM	Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test, Further Extending Its Best-in-Class Performance (Business Wire)
01:38AM	Guardant settles allegations it violated the False Claims Act (MedTech Dive)
Jul-21-24 06:00AM	3 Precision Medicine Stocks Tailoring Treatments (InvestorPlace)
05:00PM	Loading…
Jul-18-24 05:00PM	Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors (Business Wire)
Jul-05-24 03:01PM	Baillie Gifford Reduces Stake in Guardant Health Inc. (GuruFocus.com)
Jul-03-24 11:11AM	3 Biotech Moonshots With Imminent Catalyst Potential (InvestorPlace)
07:00AM	The 3 Best Personalized Medicine Stocks to Buy in July 2024 (InvestorPlace)
Jul-02-24 06:15AM	From Sell' to Strong Buy': 3 Dramatic Analyst U-Turns to Watch (InvestorPlace)
Jun-27-24 03:28PM	American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond (PR Newswire)
Jun-26-24 09:35AM	Guardant Health (GH) Just Overtook the 20-Day Moving Average (Zacks)
Jun-25-24 09:55AM	Guardant Health (GH) Now Trades Above Golden Cross: Time to Buy? (Zacks)
Jun-04-24 08:05AM	Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer (Business Wire)
Jun-03-24 09:18AM	Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials (Business Wire)
May-31-24 08:05AM	Guardant Health Named to TIME100 Most Influential Companies (Business Wire)
May-30-24 08:05AM	Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening (Business Wire) +5.29%
May-27-24 11:34AM	Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns (InvestorPlace)
09:30AM	Guardant Health (GH) Recently Broke Out Above the 200-Day Moving Average (Zacks)
May-24-24 04:06PM	Guardant Health Jumps As Exact Sciences Slumps On A Key FDA Move For Blood Tests (Investor's Business Daily) +13.37%
01:16PM	Guardant Health Stock Jumps 12% (Barrons.com)
01:15PM	Guardant Health Stock Jumps. Blood Test for Cancer Moves Toward FDA Approval. (Barrons.com)
10:28AM	Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok (The Wall Street Journal)
09:03AM	Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test (Investor's Business Daily)
08:37AM	Guardant wins FDA AdCom backing for colon cancer test (Medical Device Network)
May-23-24 07:03PM	FDA Advisory Committee Panel Strongly Recommends Approval of Shield Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option (Business Wire)
10:52AM	Guardant Health's blood test to detect deadly colon cancer is under review by the FDA (Quartz)
07:05AM	Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening (Business Wire)
May-22-24 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire) +13.37%
08:15AM	Guardant colon cancer test struggles to detect non-cancerous tumors, FDA says (MedTech Dive)
May-21-24 04:36PM	What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday? (Benzinga)
09:53AM	Guardant Health Gets EU Certification for Blood-Based Test for Comprehensive Genomic Profiling of Solid Cancers (MT Newswires)
08:05AM	Guardant Health Receives EU IVDR Certification for Guardant360 CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications (Business Wire)
May-17-24 08:05AM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-16-24 08:05AM	Guardant Health to present real-world data supporting performance of Shield blood test for colorectal cancer screening at 2024 Digestive Disease Week (Business Wire)
May-15-24 06:45PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
May-13-24 10:03AM	Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript (Insider Monkey) +7.29%
May-10-24 06:16PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +15.07%
01:58PM	Guardant Health Shares Rise After Q1 Adjusted Loss Shrinks, Revenue Rises; 2024 Revenue Guidance Raised (MT Newswires)
01:09PM	Guardant Health Inc (GH) Reports Strong Q1 2024 Earnings, Surpasses Revenue Estimates (GuruFocus.com)
May-09-24 06:30PM	Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics (Zacks)
06:05PM	Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:58PM	Guardant Health: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (Business Wire)
May-07-24 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
11:29AM	Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect (Zacks)
08:00AM	Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone (Business Wire)
May-06-24 09:15AM	Curious about Guardant Health (GH) Q1 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Apr-29-24 04:01PM	Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors (PR Newswire)
11:18AM	Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating (MT Newswires)
Apr-22-24 08:52AM	FDA Advisory Panel Review of Guardant Healths Shield Blood Test to Screen for Colorectal Cancer to Be Held on May 23 (Business Wire) +9.46%
Apr-18-24 04:05PM	Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Apr-03-24 08:05AM	Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting (Business Wire) -5.24%
Apr-02-24 04:02PM	Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales (Investor's Business Daily)
Apr-01-24 08:35AM	Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks. (InvestorPlace)
Mar-30-24 07:43PM	20 Foods To Reduce Cancer Risk (Insider Monkey)
Mar-13-24 05:09PM	A blood test for colon cancer performed well in a study, expanding options for screening (Associated Press Finance)
05:00PM	Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine (Business Wire)
Mar-06-24 04:30PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +7.58%
Mar-01-24 05:30AM	New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap (Business Wire)
Feb-28-24 06:46PM	21 Countries that Have the Highest Rates of Cancer Deaths (Insider Monkey)
Feb-26-24 02:13AM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Feb-23-24 11:48AM	Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript (Insider Monkey) -12.80%
Feb-22-24 07:00PM	Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
06:20PM	Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:23PM	Guardant Health: Q4 Earnings Snapshot (Associated Press Finance)
04:38PM	Guardant Health Inc (GH) Reports 25% Revenue Growth in Full Year 2023 (GuruFocus.com)
04:05PM	Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook (Business Wire)
09:55AM	Wall Street Analysts Think Guardant Health (GH) Could Surge 109.89%: Read This Before Placing a Bet (Zacks)
Feb-16-24 03:10AM	15 Best Hospitals for Cancer Treatment in the US (Insider Monkey)
Feb-15-24 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
10:00AM	Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-07-24 09:00AM	Cathie Wood Is Selling This Stock: Should You? (Motley Fool)
Feb-02-24 09:35AM	Down -12.91% in 4 Weeks, Here's Why Guardant Health (GH) Looks Ripe for a Turnaround (Zacks)
Feb-01-24 04:05PM	Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 (Business Wire)

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Joyce Meghan V.	Director	Sep 04 '24	Option Exercise	0.00	67	0	10,412	Sep 05 04:52 PM
Saia John G.	Chief Legal Officer	Sep 01 '24	Option Exercise	0.00	263	0	29,306	Sep 03 04:47 PM
Kalia Kumud	Chief Information Officer	Sep 01 '24	Option Exercise	0.00	710	0	18,666	Sep 03 04:46 PM
Chudova Darya	Chief Technology Officer	Sep 01 '24	Option Exercise	0.00	316	0	44,379	Sep 03 04:45 PM
Krognes Steve E.	Director	Aug 31 '24	Option Exercise	0.00	155	0	9,603	Sep 03 04:43 PM
Tariq Musa	Director	Aug 15 '24	Option Exercise	0.00	250	0	4,247	Aug 19 05:18 PM
POTTER MYRTLE S	Director	Aug 15 '24	Option Exercise	0.00	68	0	13,448	Aug 19 05:17 PM
Joyce Meghan V.	Director	Aug 04 '24	Option Exercise	0.00	66	0	10,345	Aug 05 06:10 PM
Krognes Steve E.	Director	Jul 31 '24	Option Exercise	0.00	154	0	9,448	Aug 01 06:46 PM
Tariq Musa	Director	Jul 15 '24	Option Exercise	0.00	250	0	3,997	Jul 16 04:35 PM
POTTER MYRTLE S	Director	Jul 15 '24	Option Exercise	0.00	69	0	13,380	Jul 16 04:33 PM
Joyce Meghan V.	Director	Jul 04 '24	Option Exercise	0.00	66	0	10,279	Jul 08 05:29 PM
Saia John G.	Chief Legal Officer	Jul 01 '24	Option Exercise	0.00	974	0	29,391	Jul 02 04:58 PM
Kalia Kumud	Chief Information Officer	Jul 01 '24	Option Exercise	0.00	1,607	0	18,530	Jul 02 04:57 PM
Freeman Chris	Chief Commercial Officer	Jul 01 '24	Option Exercise	0.00	1,928	0	26,527	Jul 02 04:55 PM
EAGLE CRAIG	Chief Medical Officer	Jul 01 '24	Option Exercise	0.00	1,714	0	19,108	Jul 02 04:54 PM
Chudova Darya	Chief Technology Officer	Jul 01 '24	Option Exercise	0.00	1,339	0	44,541	Jul 02 04:53 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 30 '24	Option Exercise	0.00	11,462	0	2,204,589	Jul 02 04:51 PM
Krognes Steve E.	Director	Jun 30 '24	Option Exercise	0.00	154	0	9,294	Jul 02 04:49 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jun 30 '24	Option Exercise	0.00	11,462	0	2,304,423	Jul 02 04:47 PM
Tariq Musa	Director	Jun 15 '24	Option Exercise	0.00	250	0	3,747	Jun 17 06:44 PM
Saia John G.	Chief Legal Officer	Jun 15 '24	Option Exercise	0.00	4,017	0	29,851	Jun 17 06:43 PM
POTTER MYRTLE S	Director	Jun 15 '24	Option Exercise	0.00	68	0	13,311	Jun 17 06:42 PM
Kalia Kumud	Chief Information Officer	Jun 15 '24	Option Exercise	0.00	2,510	0	17,819	Jun 17 06:41 PM
Freeman Chris	Chief Commercial Officer	Jun 15 '24	Option Exercise	0.00	10,402	0	27,469	Jun 17 06:40 PM
EAGLE CRAIG	Chief Medical Officer	Jun 15 '24	Option Exercise	0.00	5,523	0	19,365	Jun 17 06:38 PM
Bell Michael Brian	Chief Financial Officer	Jun 15 '24	Option Exercise	0.00	9,267	0	21,720	Jun 17 06:37 PM
POTTER MYRTLE S	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	13,243	Jun 13 08:58 PM
Krognes Steve E.	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	9,140	Jun 13 08:56 PM
Joyce Meghan V.	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	10,213	Jun 13 08:54 PM
Gadde Vijaya	Director	Jun 12 '24	Option Exercise	0.00	5,592	0	17,640	Jun 13 08:53 PM
CLARK IAN T	Director	Jun 12 '24	Option Exercise	0.00	6,776	0	15,677	Jun 13 08:51 PM
Joyce Meghan V.	Director	Jun 04 '24	Option Exercise	0.00	67	0	4,721	Jun 05 04:56 PM
Joyce Meghan V.	Director	Jun 04 '24	Sale	27.87	100	2,787	4,621	Jun 05 04:56 PM
Saia John G.	Chief Legal Officer	Jun 01 '24	Option Exercise	0.00	263	0	25,928	Jun 03 06:25 PM
Kalia Kumud	Chief Information Officer	Jun 01 '24	Option Exercise	0.00	711	0	15,563	Jun 03 06:23 PM
Chudova Darya	Chief Technology Officer	Jun 01 '24	Option Exercise	0.00	315	0	43,315	Jun 03 06:21 PM
Krognes Steve E.	Director	May 31 '24	Option Exercise	0.00	155	0	3,548	Jun 03 06:20 PM
Tariq Musa	Director	May 15 '24	Option Exercise	0.00	250	0	3,497	May 16 06:17 PM
POTTER MYRTLE S	Director	May 15 '24	Option Exercise	0.00	69	0	7,651	May 16 06:15 PM
EAGLE CRAIG	Chief Medical Officer	May 15 '24	Option Exercise	0.00	3,717	0	15,169	May 16 06:14 PM
Chudova Darya	Chief Technology Officer	May 15 '24	Option Exercise	0.00	8,705	0	46,106	May 16 06:12 PM
Joyce Meghan V.	Director	May 04 '24	Option Exercise	0.00	66	0	4,654	May 06 05:06 PM
Eltoukhy Helmy	Co-Chief Executive Officer	May 03 '24	Option Exercise	4.18	200,000	836,000	2,292,961	May 06 05:05 PM
Talasaz AmirAli	Co-Chief Executive Officer	May 02 '24	Option Exercise	4.18	283,830	1,186,409	2,193,127	May 06 05:03 PM
Krognes Steve E.	Director	Apr 30 '24	Option Exercise	0.00	154	0	3,393	May 02 05:03 PM
Tariq Musa	Director	Apr 15 '24	Option Exercise	0.00	249	0	3,247	Apr 16 06:36 PM
Saia John G.	Chief Legal Officer	Apr 15 '24	Option Exercise	0.00	7,569	0	28,366	Apr 16 06:35 PM
POTTER MYRTLE S	Director	Apr 15 '24	Option Exercise	0.00	68	0	7,582	Apr 16 06:33 PM
Joyce Meghan V.	Director	Apr 04 '24	Option Exercise	0.00	67	0	4,588	Apr 05 06:29 PM
Saia John G.	Chief Legal Officer	Apr 01 '24	Option Exercise	0.00	974	0	22,305	Apr 02 06:09 PM
Kalia Kumud	Chief Information Officer	Apr 01 '24	Option Exercise	0.00	1,607	0	14,329	Apr 02 06:08 PM
Freeman Chris	Chief Commercial Officer	Apr 01 '24	Option Exercise	0.00	1,929	0	16,502	Apr 02 06:06 PM
EAGLE CRAIG	Chief Medical Officer	Apr 01 '24	Option Exercise	0.00	1,714	0	12,073	Apr 02 06:05 PM
Chudova Darya	Chief Technology Officer	Apr 01 '24	Option Exercise	0.00	1,340	0	36,831	Apr 02 06:04 PM
Krognes Steve E.	Director	Mar 31 '24	Option Exercise	0.00	154	0	3,239	Apr 01 05:25 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 31 '24	Option Exercise	0.00	11,461	0	1,913,806	Apr 01 05:23 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 31 '24	Option Exercise	0.00	11,461	0	2,097,470	Apr 01 05:20 PM
Kalia Kumud	Chief Information Officer	Mar 18 '24	Buy	17.82	2,187	38,963	12,722	Mar 19 05:29 PM
Tariq Musa	Director	Mar 15 '24	Option Exercise	0.00	2,998	0	2,998	Mar 18 06:16 PM
POTTER MYRTLE S	Director	Mar 15 '24	Option Exercise	0.00	68	0	7,514	Mar 18 06:14 PM
Bell Michael Brian	Chief Financial Officer	Mar 15 '24	Option Exercise	0.00	1,233	0	12,882	Mar 18 06:12 PM
Joyce Meghan V.	Director	Mar 04 '24	Option Exercise	0.00	66	0	4,621	Mar 05 08:01 PM
Joyce Meghan V.	Director	Mar 04 '24	Sale	19.05	100	1,905	4,521	Mar 05 08:01 PM
Saia John G.	Chief Legal Officer	Mar 01 '24	Option Exercise	0.00	263	0	21,439	Mar 04 06:39 PM
Merrill Amelia	SVP, People	Mar 01 '24	Option Exercise	0.00	158	0	27,540	Mar 04 06:37 PM
Kalia Kumud	Chief Information Officer	Mar 01 '24	Option Exercise	0.00	710	0	10,789	Mar 04 06:35 PM
Chudova Darya	Chief Technology Officer	Mar 01 '24	Option Exercise	0.00	316	0	35,621	Mar 04 06:34 PM
Krognes Steve E.	Director	Feb 29 '24	Option Exercise	0.00	154	0	3,085	Mar 01 05:08 PM
POTTER MYRTLE S	Director	Feb 15 '24	Option Exercise	0.00	69	0	7,446	Feb 16 07:10 PM
Joyce Meghan V.	Director	Feb 04 '24	Option Exercise	0.00	66	0	4,555	Feb 05 08:12 PM
Krognes Steve E.	Director	Jan 31 '24	Option Exercise	0.00	155	0	2,931	Feb 01 05:38 PM
Chudova Darya	Chief Technology Officer	Jan 16 '24	Option Exercise	8.80	6,626	58,309	35,305	Jan 16 07:44 PM
POTTER MYRTLE S	Director	Jan 15 '24	Option Exercise	0.00	68	0	7,377	Jan 16 07:43 PM
Bell Michael Brian	Chief Financial Officer	Jan 15 '24	Option Exercise	0.00	3,308	0	13,005	Jan 16 07:41 PM
Kalia Kumud	Chief Information Officer	Jan 07 '24	Option Exercise	0.00	5,376	0	12,250	Jan 08 07:45 PM
Joyce Meghan V.	Director	Jan 04 '24	Option Exercise	0.00	67	0	4,489	Jan 05 04:58 PM
Saia John G.	Chief Legal Officer	Jan 01 '24	Option Exercise	0.00	974	0	21,576	Jan 03 07:51 PM
Merrill Amelia	SVP, People	Jan 01 '24	Option Exercise	0.00	482	0	27,580	Jan 03 07:49 PM
Kalia Kumud	Chief Information Officer	Jan 01 '24	Option Exercise	0.00	1,607	0	7,533	Jan 03 07:48 PM
Freeman Chris	Chief Commercial Officer	Jan 01 '24	Option Exercise	0.00	1,928	0	15,207	Jan 03 07:45 PM
EAGLE CRAIG	Chief Medical Officer	Jan 01 '24	Option Exercise	0.00	1,714	0	11,062	Jan 03 07:44 PM
Chudova Darya	Chief Technology Officer	Jan 01 '24	Option Exercise	0.00	1,339	0	29,228	Jan 03 07:42 PM
Krognes Steve E.	Director	Dec 31 '23	Option Exercise	0.00	154	0	2,776	Jan 02 06:06 PM
POTTER MYRTLE S	Director	Dec 15 '23	Option Exercise	0.00	69	0	7,309	Dec 18 05:39 PM
Bell Michael Brian	Chief Financial Officer	Dec 15 '23	Option Exercise	0.00	1,233	0	10,124	Dec 18 05:37 PM
Joyce Meghan V.	Director	Dec 04 '23	Option Exercise	0.00	66	0	4,522	Dec 05 05:01 PM
Joyce Meghan V.	Director	Dec 04 '23	Sale	26.34	100	2,634	4,422	Dec 05 05:01 PM
Saia John G.	Chief Legal Officer	Dec 01 '23	Option Exercise	0.00	263	0	20,733	Dec 04 06:28 PM
Merrill Amelia	SVP, People	Dec 01 '23	Option Exercise	0.00	158	0	27,153	Dec 04 06:26 PM
Kalia Kumud	Chief Information Officer	Dec 01 '23	Option Exercise	0.00	710	0	12,079	Dec 04 06:25 PM
Kalia Kumud	Chief Information Officer	Dec 01 '23	Sale	26.37	5,800	152,954	5,926	Dec 04 06:25 PM
Chudova Darya	Chief Technology Officer	Dec 01 '23	Option Exercise	0.00	315	0	27,998	Dec 04 06:24 PM
Krognes Steve E.	Director	Nov 30 '23	Option Exercise	0.00	154	0	2,622	Dec 04 06:22 PM
Chudova Darya	Chief Technology Officer	Nov 15 '23	Option Exercise	8.80	4,000	35,200	27,683	Nov 16 05:04 PM
POTTER MYRTLE S	Director	Nov 15 '23	Option Exercise	0.00	68	0	7,240	Nov 16 05:02 PM
Joyce Meghan V.	Director	Nov 04 '23	Option Exercise	0.00	66	0	4,456	Nov 06 05:40 PM
Krognes Steve E.	Director	Oct 31 '23	Option Exercise	0.00	154	0	2,468	Nov 01 08:07 PM
POTTER MYRTLE S	Director	Oct 15 '23	Option Exercise	0.00	68	0	7,172	Oct 16 06:28 PM
Joyce Meghan V.	Director	Oct 04 '23	Option Exercise	0.00	67	0	4,390	Oct 05 06:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your FINVIZ experience